Biomarker signatures in cancer patients with and without venous thromboembolism events: a substudy of CASSINI.

Khorana, Alok A; Barnard, John; Wun, Ted; Vijapurkar, Ujjwala; Damaraju, C V; Moore, Kenneth Todd; Wildgoose, Peter; McCrae, Keith R

Khorana, Alok A; Barnard, John; Wun, Ted; Vijapurkar, Ujjwala; Damaraju, C V; Moore, Kenneth Todd; Wildgoose, Peter; McCrae, Keith R.

Affiliation

Khorana AA; Taussig Cancer Institute and Case Comprehensive Cancer Center, and.
Barnard J; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
Wun T; Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA; and.
Vijapurkar U; Janssen Scientific Affairs, LLC, Titusville, NJ.
Damaraju CV; Janssen Scientific Affairs, LLC, Titusville, NJ.
Moore KT; Janssen Scientific Affairs, LLC, Titusville, NJ.
Wildgoose P; Janssen Scientific Affairs, LLC, Titusville, NJ.
McCrae KR; Taussig Cancer Institute and Case Comprehensive Cancer Center, and.

Blood Adv ; 6(4): 1212-1221, 2022 02 22.

Article in En | MEDLINE | ID: mdl-34807979

Subject(s)

Neoplasms; Venous Thromboembolism; Bayes Theorem; Biomarkers; Female; Humans; Male; Neoplasms/complications; Prospective Studies; Thyrotropin; Venous Thromboembolism/diagnosis; Venous Thromboembolism/etiology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Venous Thromboembolism / Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Blood Adv Year: 2022 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google